Rentokil Initial

Quarterly Financials

Values in thousands 2024-06-30 2023-12-31 2023-06-30 2023-03-31
Revenue
$2,706,000
$2,704,000
$2,671,000
$2,141,900
Gross Profit
385,000
399,000
363,000
284,200
EBITDA
525,000
520,000
597,000
418,800
EBIT
360,000
399,000
363,000
284,200
Net Income
196,000
196,000
185,000
107,800
Net Change In Cash
2,706,000
2,704,000
2,671,000
2,141,900
Free Cash Flow
223,000
300,000
230,000
235,600
Cash
1,557,000
1,562,000
1,418,000
2,170,000
Basic Shares
2,530,000
2,527,000
2,527,000
2,216,386

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$5,375,000
$3,714,000
$2,953,900
$2,789,400
Gross Profit
1,497,000
977,000
714,800
653,000
EBITDA
1,157,000
767,000
656,000
581,000
EBIT
682,000
381,000
329,500
256,300
Net Income
381,000
232,000
263,000
186,000
Net Change In Cash
5,375,000
3,714,000
2,953,900
2,789,400
Free Cash Flow
530,000
410,000
403,300
382,600
Cash
1,562,000
2,170,000
668,400
1,949,500
Basic Shares
2,527,000
2,014,000
1,866,300
1,862,900

Earnings Calls

Quarter EPS
2024-03-31
$0
2023-12-31
$0
2023-09-30
$0
2023-06-30
$0.72